[Nuclear factor kappa B (NF-kappa B). II. Pathophysiologic meaning].
Messer
G
G
Klinik und Poliklinik für Dermatologie und Allergologie der Ludwig-Maximilians-Universität München, Frauenlobstrasse 9-11, 80337 München. Gerald.Messer@lrz.uni-muenchen.de
Rupec
R A
RA
D000210:Acute-Phase Reaction / Q000209:etiology; D000287:Administration, Topical; D000818:Animals; D000875:Anthralin / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000494:pharmacology / Q000627:therapeutic use; D001327:Autoimmune Diseases / Q000235:genetics / Q000503:physiopathology; D003876:Dermatitis, Atopic / Q000235:genetics / Q000503:physiopathology; D005260:Female; D006689:Hodgkin Disease / Q000235:genetics / Q000503:physiopathology; D006706:Homeostasis; D006801:Humans; D007166:Immunosuppressive Agents / Q000494:pharmacology; D007184:Incontinentia Pigmenti / Q000235:genetics; D007231:Infant, Newborn; D007249:Inflammation / Q000209:etiology / Q000503:physiopathology; D008297:Male; D008545:Melanoma / Q000235:genetics / Q000503:physiopathology; D051379:Mice; D018345:Mice, Knockout; D016328:NF-kappa B / Q000037:antagonists & inhibitors / Q000235:genetics / Q000502:physiology*; D019001:Nitric Oxide Synthase / Q000378:metabolism / Q000502:physiology; D011565:Psoriasis / Q000188:drug therapy / Q000235:genetics / Q000503:physiopathology; D012871:Skin Diseases / Q000188:drug therapy / Q000235:genetics / Q000503:physiopathology*; D012878:Skin Neoplasms / Q000235:genetics / Q000503:physiopathology; D014777:Virus Diseases / Q000503:physiopathology
D000893:Anti-Inflammatory Agents; D007166:Immunosuppressive Agents; D016328:NF-kappa B; D019001:Nitric Oxide Synthase; D000875:Anthralin